Hologen
PrivateLast Round
Series A
Jan 28, 2026
Est. Valuation
$1B
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Hologen operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a VC Round in November 2025.
Hologen is an AI biotechnology company that develops multi-modal generative AI models to improve the understanding, design, evaluation, and delivery of treatments for neurological and other complex health conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hologen Comparables
Compare Hologen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bioptimus | 84% | |
| BenevolentAI | 83% | |
| Insilico Medicine | 83% |
For institutional investors. Book with your work email.
Hologen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 28, 2026 | ||||
| VC Round | Nov 27, 2025 | ||||
| Seed | Jul 1, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Hologen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 2468 Ventures | Seed |
| Gaingels | Seed |
| SW7 Group | Seed |
| UCL Business | Seed |
| Meridian Health Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2026
Grew 20% QoQ, from 35 to 42 employees.
- Sep 14, 2026
Monthly visitors increased 57% MoM, reaching 8.4K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withNov 9, 2026
Hologen and Sysmex Corporation establish Saibogen, a joint venture that uses generative AI to turn routine blood test data into clinical intelligence, on Nov 9th '26, in the United Kingdom and Japan.
For institutional investors. Book with your work email.
Hologen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hologen's valuation, stock price, and market status.
Is Hologen a public or private company?
Hologen is a private company.
What is the current stock price of Hologen?
Hologen is a private company, so its shares have no public market price. Caplight tracks Hologen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hologen worth (valuation)?
Hologen's valuation is estimated at $1.0B based on funding round data.
Can I buy Hologen stock?
Hologen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hologen's last funding round?
Hologen's most recent funding round was Series A on January 28, 2026.
Who are the main investors in Hologen?
Key investors in Hologen include Meridian Health Ventures.
Will Hologen IPO soon?
No public IPO plans have been announced for Hologen.
How can I track Hologen secondary market activity?
Caplight tracks bids, offers, and trades in Hologen's shares on secondary markets.